Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982 Jun;44(6):339-48.
doi: 10.1007/BF00319917.

Prognostic factors in COPP-treated patients with Hodgkin's disease

Prognostic factors in COPP-treated patients with Hodgkin's disease

W Gassmann et al. Blut. 1982 Jun.

Abstract

In a recently published review of the literature [40] we came to the conclusion that the Ann-Arbor staging classification is of limited prognostic value for chemotherapy of Hodgkin's disease (Table 2). Four risk factors accounted for impaired complete remission rates: stage IVB, lymphocyte depletion or not classifiable histologic type, previous chemotherapy, and older age. Fifty-eight evaluable patients were treated with COPP; 23 reached a complete remission (40%). Disease-free survival was 31%, overall survival 49% after five years [33]. Besides the known risk factors, impaired bone marrow function (leucocyte counts less than 4 X 10(9)/l, platelet counts less than 100 X 10(9)/l) at the start of therapy was associated with poor treatment results: none of six patients achieved a complete remission [41]. Eleven of 16 patients with no and 11 of 23 patients with one risk factor achieved a complete remission, as did only one patient with more than one risk factor. Survival rates after 30 months were: 87% with no, 66% with one, 36% with two, and 13% with more than two risk factors. We can conclude from our results that the prognosis of patients undergoing chemotherapy for Hodgkin's disease depends on the number of risk factors.

PubMed Disclaimer

Similar articles

References

    1. Cancer. 1975 Oct;36(4):1227-40 - PubMed
    1. Cancer. 1978 Nov;42(5):2101-10 - PubMed
    1. Cancer. 1980 Oct 15;46(8):1735-40 - PubMed
    1. Cancer. 1978 Aug;42(2 Suppl):1001-7 - PubMed
    1. Clin Oncol. 1977 Jun;3(2):145-54 - PubMed

LinkOut - more resources